药明康德

- 603259

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
药明康德(603259) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入798,193.424,034,080.692,954,132.611,887,128.55896,374.16
营业收入798,193.424,034,080.692,954,132.611,887,128.55896,374.16
二、营业总成本564,390.892,870,859.082,039,075.491,315,519.22677,522.86
营业成本493,838.252,372,879.961,734,130.721,122,547.78538,788.15
营业税金及附加6,853.2029,747.9417,599.0111,690.086,028.09
销售费用17,909.3970,102.9752,122.0435,347.4117,585.38
管理费用57,585.97287,877.08197,987.56127,285.2164,904.27
财务费用-42,436.18-33,811.92-65,344.95-48,055.7714,486.87
研发费用30,640.26144,063.04102,581.1166,704.5035,730.10
资产减值损失----------
公允价值变动收益-8,401.15-3,780.9110,267.6131,099.2116,460.85
投资收益-892.5123,384.9046,343.6932,022.2717,755.93
其中:对联营企业和合营企业的投资收益3,414.39-6,755.99-5,158.31-6,877.89-3,750.05
汇兑收益----------
三、营业利润230,984.721,187,228.59980,741.65641,244.05261,535.48
加:营业外收入166.431,659.63662.43494.04381.44
减:营业外支出1,411.745,689.123,207.452,216.801,029.65
其中:非流动资产处置损失----------
四、利润总额229,739.411,183,199.10978,196.63639,521.29260,887.28
减:所得税费用33,854.09213,173.10163,331.92103,831.6742,306.81
五、净利润195,885.32970,026.00814,864.71535,689.62218,580.46
归属于母公司所有者的净利润194,221.07960,674.91807,640.72531,311.97216,812.84
少数股东损益1,664.259,351.097,223.994,377.651,767.63
六、每股收益
基本每股收益(元/股)0.67003.27002.75001.81000.7400
稀释每股收益(元/股)0.66003.24002.73001.79000.7200
七、其他综合收益-21,372.148,692.09-54,393.58-51,366.85-1,791.58
八、综合收益总额174,513.18978,718.09760,471.13484,322.77216,788.88
归属于母公司所有者的综合收益总额173,184.52969,505.24754,124.38480,696.65214,960.14
归属于少数股东的综合收益总额1,328.669,212.856,346.763,626.121,828.74
下载全部历史数据到excel中 返回页顶